Document is current
Any future updates will be listed below
-
Authors
Poisson, Caroline
Duflot-Boukobza, Adeline
Mathivon, Delphine
Khettab, Mohamed
Ferrua, Marie
Fourcade, Aude
Lezghed, Naïma
Dhermain, Frédéric
Lemare, François
Puglisi, Vanessa
Abbas, May
Di Palma, Mario
Scotté, Florian
Minvielle, Etienne
Mir, Olivier
Guyon, David
Dumont, Sarah N.
- License Information
-
More Information
Article History
Received: 23 July 2025
Accepted: 26 December 2025
First Online: 15 January 2026
Competing interests
: F.S. declares conflicts related to BMS, Pfizer, Sanofi, Roche, MSD, Leo Pharma, Amgen, Pierre Fabre Oncologie, Gilead, Pharmanovia, Daiichi Sankyo, Thermo Fisher, Viatris, and GSK. M.D.P. declares conflicts related to Bayer, Sandoz, Pierre Fabre Oncologie, Astellas, Janssen, Roche, Sanofi, AMGEN, KyowaKirin, MSD, Mundipharma, Gilead, Novartis, AstraZeneca, Pfizer, Viatris. OM is an employee and shareholder of Amgen, Inc.
